ClearLight Diagnostics Announces the Appointment of Laurie Goodman, PhD as Interim Chief Executive Officer and the Close of an Additional Round of Funding

SUNNYVALE, CA May 8, 2018 (PR NEWSWIRE) ClearLight Diagnostics, LLC (ClearLight), an early stage developer of an automated, next generation tissue processing and 3D imaging/image analysis platform, announced today that Laurie Goodman, PhD, Chief Scientific Officer, has assumed the position of Interim Chief Executive Officer and has been selected as a Board Member. Dr. Goodman […]

ClearLight Diagnostics to Present at the 10th Annual Biotech Showcase™

SUNNYVALE, CA         January 3, 2018 (PR NEWSWIRE) ClearLight Diagnostics, LLC (ClearLight), a developer of an automated, next generation tissue processing and 3D imaging platform, today announced that Sarah McCurdy, Chief Executive Officer, will present at the 10th Annual Biotech ShowcaseTM, taking place January 8 -10 at the Hilton San Francisco Union Square. ClearLight is […]

ClearLight Diagnostics to Present Data on the 3D Imaging of Biomarkers in Core Needle Biopsies of Breast Cancer Patients

Posted: December 4, 2017 source: PRNewswire SUNNYVALE, CA December 4, 2017 (PR NEWSWIRE) ClearLight Diagnostics, LLC, a developer of an automated next generation tissue processing and 3D imaging platform, announced today that it will present data at the 2017 San Antonio Breast Cancer Symposium (SABCS) in San Antonio, Texas. Poster title: Three-dimensional (3D) Imaging of […]

ClearLight Diagnostics Licenses Exclusive Intellectual Property Rights for 3D Visualization, Image Processing, and Novel CLARITY-based Tissue Clearing Instrumentation

SUNNYVALE, CA November 7, 2017 (PR NEWSWIRE) ClearLight Diagnostics, LLC (ClearLight), a developer of a next generation tissue processing and 3D imaging platform for cancer tissue, announced today that it has licensed additional technology from Stanford University.  The new license agreement provides exclusive intellectual property rights covering inventions that can be applied to CLARITY processed […]

ClearLight Diagnostics and Researchers at the Indiana University’s Melvin and Bren Simon Cancer Center Announce a Collaboration to Profile the Tumor Microenvironment in Patients with Breast Cancer

source: PRNewswire SUNNYVALE, Calif., May 3, 2017 (PR NEWSWIRE) ClearLight Diagnostics, LLC, (ClearLight) a developer of a next generation tissue processing and 3D imaging platform, announced today that it has signed a collaboration agreement with the Indiana University Melvin and Bren Simon Cancer Center to study the tumor microenvironment in patients with breast cancer. Working […]

Poster #5915: Three-dimensional (3-D) Multiplex Imaging of Biomarkers in Tumor Tissue

ClearLight Diagnostics presented its poster #5915 on Wednesday, April 5 at the 2017 American Association for Cancer Research meeting in Washington DC.   The poster, titled: Three-dimensional (3-D) Multiplex Imaging of Biomarkers in Tumor Tissue illustrates the process of obtaining high-resolution information from solid tumors, while maintaining the spatial perspective needed to understand the heterogeneous […]

ClearLight Diagnostics to Present Data on the Multiplex 3D Imaging of the Tumor Microenvironment in a Variety of Preclinical and Clinical Cancer Models

source: PRNewswire SUNNYVALE, Calif., March 29, 2017 (PR NEWSWIRE) ClearLight Diagnostics, LLC, a developer of an automated next generation tissue processing and 3D imaging platform, announced today that it will present data at the 2017 American Association for Cancer Research meeting in Washington DC. Poster title: Three-dimensional (3-D) Multiplex Imaging of Biomarkers in Tumor Tissue […]

ClearLight Diagnostics Raises $3.5M

source: PRNewswire SUNNYVALE, Calif., December 6, 2016 (PR NEWSWIRE) ClearLight Diagnostics, LLC, a developer of a next generation tissue processing and 3D imaging platform for research and diagnostic applications, announced today that it has completed a $3.5M financing round. Existing investors, a syndicate created by Wiegers Capital Partners, LLC led the round. The financing will […]

ClearLight Diagnostics Licenses Exclusive Intellectual Property Rights from Stanford University for SPED microscopy and RNA Interrogation Technology in CLARITY Processed Tissue Samples

source: PRNewswire SUNNYVALE, Calif., November 8, 2016 (PR NEWSWIRE) ClearLight Diagnostics, LLC (ClearLight), a developer of a next generation tissue processing and 3D imaging platform for research and diagnostic applications, announced today that it has signed an exclusive, worldwide license agreement with Stanford University. The license agreement provides exclusive intellectual property rights covering inventions relating […]

ClearLight Diagnostics and the OHSU Center for Spatial Systems Biomedicine Collaborate to Define Tumor Microenvironment in Pancreatic Cancer

source: PRNewswire SUNNYVALE, Calif., October 3, 2016 (PR NEWSWIRE) ClearLight Diagnostics, LLC (ClearLight) announced today that it has signed a collaboration agreement with the Oregon Health & Science University Center for Spatial Systems Biomedicine (OCSSB) to study the tumor microenvironment in patients with cancer. “As we launch our first academic collaboration, we are excited to […]